Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19.from IndiaTV India: Google News Feed https://ift.tt/3yHpXKk
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.